For the Inventor, By the Inventor

Enter assignee name

Ness Ziona, Israel

Sol-Gel Technologies Ltd.

Calculating rank

USPTO Granted Patents = 42

% Expired Patents = 11.9

CIPO Patents = 4

EPO Patents = 12

Trademarks = 2

Forward Citations = 599

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Ofer Toledano (26 out of 29 patents)

Hanan Sertchook (11 out of 13 patents)

Ori Nov (10 out of 10 patents)

4. Haim Bar-Simantov (10 out of 11 patents)

5. Noa Lapidot (9 out of 29 patents)

6. Claudio Rottman (9 out of 19 patents)

7. Shlomo Magdassi (7 out of 47 patents)

8. David Avnir (7 out of 21 patents)

9. Orit Gans (7 out of 7 patents)

10. Alon Seri-Levy (7 out of 14 patents)

11. Ofra Levy-Hacham (6 out of 6 patents)

12. Raed Abu-Reziq (5 out of 9 patents)

13. Dorit Marco (5 out of 7 patents)

14. Vered Ram (5 out of 5 patents)

15. Karine Neimann (5 out of 7 patents)

Core Competencies:

Silica Microspheres

Microcapsules

Rosacea Treatment

Topical Formulations

Active Ingredients

Metal Oxide Coating

Sunscreen Compositions

Stabilized Formulations

Glycopyrrolate Tosylate

Acne Treatment

Core-Shell Particles

Enhanced Stability

42 patents: Sort by Forward Citations

1. 12758534 - Treatment and prevention of basal cell carcinoma with topical composition comprising patidegib (2026-10-13),

2. RE50804 - Pharmaceutical compositions comprising silica microspheres (2026-02-24),

3. 12295935 - Method for therapeutic treatment of rosacea (2025-05-13),

4. 12257348 - Stabilized microcapsules, method of their preparation and uses thereof (2025-03-25),

5. 12156946 - Method for preparing particles comprising metal oxide coating and particles with metal oxide coating (2024-12-03),

6. 12133919 - Stabilized microcapsules, method of their preparation and uses thereof (2024-11-05),

7. 12070629 - Core stabilized microcapsules, method of their preparation and uses thereof (2024-08-27),

8. 12053546 - Stabilized topical formulations containing core-shell microcapsules (2024-08-06),

9. 11986456 - Method for treatment of rosacea (2024-05-21),

10. 11877997 - Method for providing early onset of action in the treatment of rosacea (2024-01-23),

11. 11865208 - Pharmaceutical compositions comprising silica microspheres (2024-01-09),

12. 11865100 - Method for treatment of rosacea in patients aged 65 years and older (2024-01-09),

13. 11633399 - Treatment of skin disorders with compositions comprising an EGFR inhibitor (2023-04-25),

14. 11628155 - Method for therapeutic treatment of rosacea (2023-04-18),

15. 11541026 - Method for treatment of rosacea (2023-01-03),

Company Overview

Sol-Gel Technologies Ltd., based in Ness Ziona, Israel, specializes in the development of innovative therapeutic treatments targeting skin conditions such as rosacea and acne. The company focuses on advanced topical formulations utilizing microencapsulation techniques, metal oxide coatings, and silica microspheres to enhance the efficacy and stability of its products. With a commitment to improving skin health, Sol-Gel leverages its expertise in dermatological applications to create effective solutions for various skin concerns.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

42 Patents

#2 in Ness Ziona

#129 in Israel

#16,383 in the World

Ness Ziona, Israel

Sol-Gel Technologies Ltd.

Forward Citations = 599

45 inventors:

Ofer Toledano (26 out of 29 patents)

Hanan Sertchook (11 out of 13 patents)

Ori Nov (10 out of 10 patents)

4. Haim Bar-Simantov (10 out of 11 patents)

5. Noa Lapidot (9 out of 29 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sol-Gel Technologies Ltd.. Retrieved from https://idiyas.com/company/sol-gel-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…